We are excited to announce the launch of GlomPedia 📖 The essential guide to glomerular diseases at your fingertips! GlomPedia is your go-to eBook library for diagnosing and managing glomerular diseases. 👉 Download it for free today on the Apple App Store and Google Play.

A culmination and a fraction of a lifetime. Thank you to everyone who made this possible. Officially a board-certified Nephrologist and a Diplomate of the PSN

🚨 The #REGENCY phase 3 trial of #obinutuzumab in #Lupus #nephritis has just been published in the NEJM!!! DOWNLOAD LINK: nejm.org/doi/full/10.10…

SGLT2i are highly effective drugs to prevent progression of CKD. However, several populations at risk (also to have CV events) are excluded from trials; also now that combination therapies are tested. A summary of my talk on SGLT2i and autoimmunity: sciencedirect.com/science/articl…

Looking forward to this “An Evidence-Based Review of the Management of Acute (In-patient) Hypertension” #Nephpearls 🗓️ February 25, 2025 (Tuesday) ⏰ 9:00 AM 📍 UP-PGH Science Hall 🇵🇭 You may join virtually via Zoom 🎧 Meeting ID: 96854707315 Meeting Passcode: IMGR2025

nejm.org/doi/full/10.10…

Anna Gaddy, MD, #renalphysisian and nondirected kidney donor: "It's pretty easy. You just call and they take care of everything. I'm really happy I did it." #RPA2025 RPA-Nephrology

A man of #humility, #hope & humour who lived a life of #service to the Church & the poor to the very last moment. Thank you Pope Leo XIV Rest in peace 🙏 Archdiocese of Dublin The Irish Catholic CatholicBishops

SGLT2 inhibitor (SGLT2i) Cold 🥶 Map: Indications for SGLT2i in CKD/ Albuminuria/ Type 2 Diabetes (T2D)/ Heart Failure (HFrEF, HFmrEF, HFpEF) from Int Society of Nephrology KDIGO RPA-Nephrology ASPC #Nephpearls #Cardiorenal 👉 theisn.org/initiatives/to…

16/ Glad I’ve bumped into new and (hopefully) future #nephjc interns at #era25

Island life perk: when a quick escape means the beach is just down the road 🌊🌴

⭐️Find out more about #NephJC internship and new interns Shellie Fravel Sejal Lakhani, DO Sejal Patel M.D.,CCRP, FASN Jeyakumar Meyyappan Marc Soco, MD Akshaya Jayachandran Dr.Sridatta A.K.A Nephron_Endowment Dr.Sai Vani The kidney whisperer Natalia Nombera Aznaran Clemens Weber Swapnil Hiremath @hswapnil.medsky.social nephjc.com/news/2025/6/21…

When your team works this hard, coaching feels easy. Mighty proud of my residents for winning this year’s Nephrology Quiz Bowl 🏆🫘

The #NephJC editorial team knows that plenty of papers deserve attention between our bi-monthly, full-length discussions ✨Enter #NephJCShorts - quick hits with a critical eye 🦅 on high-impact reads nephjc.com/news/nephjc-sh…

With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?' ✍️#NephJC summary by Sejal Lakhani, DO and Jeyakumar Meyyappan ⏰🦋Chat happening on July 8, 9 pm EST nephjc.com/news/confidenc…

1/10 Last #NephJC we discussed the combination therapy of empagliflozin and finerenone 💊 #TenPostNephJC 🌵From a therapeutic dessert to a flood of options in DKD - what is the best timing to keep the kidneys afloat

It's finally here!! #NephJC summer book club 📚 Everything is Tuberculosis by 🐢🐢🐢John Green🐢🐢🐢 8/19/25 @ 9pm EST, only on #BlueSky Come for the discussion, stay for stories. nephjc.com/news/2025/8/17…

It's that time of year again 🍂🍂🍂 The #NephJC Fall pledge drive. Plese give if you are able to support our decades long mission of #FOAMed for all. #NephTwitter #MedTwitter nephjc.com/news/2025/9/22…

Check at the VA for our discussion of protein diet strategies by Marc Soco, MD . Is restricting protein in CKD and pushing protein in ESRD #TWDFNR? nephjc.com/news/2025/10/1…

It’s 2025 and we’re still dosing drugs like it’s 1976. The saga of Cockcroft–Gault, FDA inertia, and the slow evolution of renal dosing equations. 🧮 pbfluids.com/2025/10/cockcr…